“driving with dementia”的搜索结果，显示 321-330 项，共有 521 项

1. 神经科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to investigate whether recent, groundbreaking discoveries about key pathophysiologic processes that drive ...

2. 亨廷顿病- 医生与科室- 妙佑医疗国际

   Erika D. Driver-Dunckley, M.D. ... Rodolfo Savica, M.D., Ph.D. Neurologist. Rochester, MN. 擅长领域：. Parkinson's disease, Dementia, Huntington's disease, ...

3. 神经科- 临床试验- 妙佑医疗国际

   There is evidence that neurodegenerative changes precede clinical symptoms in Alzheimer's disease by two decades (Villemagne et al, 2013). Early detection is ...

4. 神经科- 临床试验- 妙佑医疗国际

   ALSENLITE: Senolytics for Alzheimer's Disease. Rochester, Minn. The purpose of this study is to measure target engagement in cerebrospinal fluid (CSF) and blood ...

5. 神经科- 临床试验- 妙佑医疗国际

   ... Alzheimer's Disease (AD) to inform and select the best blood, CSF ... Magnetic Resonance Elastography of Dementia. Rochester, Minn. The purpose of ...

6. 神经科- 临床试验- 妙佑医疗国际

   ALSENLITE: Senolytics for Alzheimer's Disease. Rochester, Minn. The purpose of this study is to measure target engagement in cerebrospinal fluid (CSF) and blood ...

7. 肌阵挛- 医生与科室- 妙佑医疗国际

   Erika D. Driver-Dunckley, M.D. ... supranuclear palsy, Lewy body dementia, Essential tremor, Dystonia, Ataxia ...

8. 神经科- 临床试验- 妙佑医疗国际

   The purpose of this study is to learn more about amyloid and tau burden in the brain of patients with Atypical Alzheimer's Disease and how that burden may ...

9. 神经科- 临床试验- 妙佑医疗国际

   Cerebrospinal Fluid (CSF) Biomarkers for Prediction of Dementia. Rochester, Minn., Jacksonville, Fla. To further investigate biomarkers in CSF as possible ...

10. 神经科- 临床试验- 妙佑医疗国际

    ... Alzheimer's Disease (AD) to inform and select the best blood, CSF ... Magnetic Resonance Elastography of Dementia. Rochester, Minn. The purpose of ...